Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Current Status of Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Clinical Review of Different Targets

  • 2050 Accesses

  • 97 Citations

Abstract

Obsessive-compulsive disorder (OCD) is a chronic psychiatric disorder that affects 2% of the general population. Despite optimal cognitive-behavioral and pharmacologic therapy, approximately 10% of patients remain treatment resistant. Currently, deep brain stimulation (DBS) is being investigated as an experimental therapy for treatment-refractory OCD. This review focuses on the efficacy and adverse events of all published DBS targets for OCD: anterior limb of the internal capsule, ventral striatum/ventral capsule, nucleus accumbens, nucleus subthalamicus, and inferior thalamic peduncle. Small studies with various designs indicate an overall average Yale-Brown Obsessive Compulsive Scale score decrease ranging from 6.8 to 31 points. The average overall responder rate is ±50%. The frequency of adverse events seems to be limited. Larger prospective studies including neuroimaging are needed to estimate adequately the true potential of DBS in treatment of OCD and to elucidate its underlying mechanism of action and optimal brain target. We conclude that DBS may be a promising and safe therapy for treatment-resistant OCD.

This is a preview of subscription content, log in to check access.

Fig. 1

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.

    Fullana MA, Mataix-Cols D, Caspi A, et al. Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. Am J Psychiatry. 2009;166(3):329–36.

  2. 2.

    Ruscio AM, Stein DJ, Chiu WT, et al. The epidemiology of obsessive compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53–63.

  3. 3.

    Denys D. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Psychiatr Clin North Am. 2006;29(2):553–84.

  4. 4.

    Lipsman N, Neimat JS, Lozano AM. Deep brain stimulation for treatment refractory obsessive-compulsive disorder: the search for a valid target. Neurosurgery. 2007;61(1):1–11.

  5. 5.

    Mindus P, Rasmussen SA, Lindquist C. Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function. J Neuropsychiatry Clin Neurosci. 1994;1:26–36.

  6. 6.

    Nuttin B, Cosyns P, Demeulemeester H, et al. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet. 1999;354(9189):1526.

  7. 7.

    Nuttin BJ, Gabriels LA, Cosyns PR, et al. Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery. 2002;52(6):1263–72.

  8. 8.

    Anderson D, Ahmed A. Treatment of patients with intractable obsessive-compulsive disorder with anterior capsular stimulation. Case report. J Neurosurg. 2003;98(5):1104–8.

  9. 9.

    Abelson JL, Curtis GC, Sagher O, et al. Deep brain stimulation for refractory obsessive compulsive disorder. Biol Psychiatry. 2005;57(5):510–6.

  10. 10.

    Greenberg BD, Price LH, Rauch SL. Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurg Clin N Am. 2003;14:199–212.

  11. 11.

    Greenberg BD, Malone DA, Friehs GM, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006;31(11):2384–93.

  12. 12.

    •• Greenberg BD, Gabriels LA, Malone DA, et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry. 2010;15(1):64–79. This multicenter study combined the results of 26 patients with comparable patient selection criteria and surgical targeting. They reported better results when ALIC–VC/VS electrodes were moved more posterior to the junction of the anterior capsule and the AC.

  13. 13.

    • Goodman WK, Foote FD, Greenberg BD, et al. Deep brain stimulation for intractable obsessive compulsive disorder, pilot study using a blinded, staggered onset design. Biol Psychiatry. 2010;67(6):535–42. This VC/VS DBS efficacy study reported four of six responders after 12 months’ follow-up.

  14. 14.

    • Figee M, Vink M, de Geus F, et al. Dysfunctional reward circuitry in obsessive-compulsive disorder. Biol Psychiatry. 2011;in press. This is the first functional imaging study to investigate explicitly reward circuitry in OCD. The authors found attenuated reward anticipation activity in the NAc compared with healthy controls.

  15. 15.

    Sturm V, Lenartz D, Koulousakis A, et al. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat. 2003;26:293–9.

  16. 16.

    • Huff W, Lenarz D, Schormann M, et al. Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: outcomes after one year. Clin Neurol Neurosurg. 2010;112(2):137–43. This unilateral (right) NAc DBS study reported 5 of 10 partial responders and 1 full responder at 1-year follow-up.

  17. 17.

    Aouizerate B, Cuny E, Martin-Guehl C, et al. Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg. 2004;101:682–6.

  18. 18.

    Franzini A, Messina G, Gambini O, et al. Deep brain stimulation of the nucleus accumbens in obsessive compulsive disorder: clinical, surgical and electrophysiological considerations in two consecutive patients. Neurol Sci. 2010;31(3):353–9.

  19. 19.

    •• Denys D, Mantione M, Figee M, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2010;67(10):1061–8. This bilateral NAc DBS study reported 9 of 16 responders with an average 72% decrease on the Y-BOCS, the largest follow-up Y-BOCS decrease published to date.

  20. 20.

    Mallet L, Mesnage V, Houeto JL, et al. Compulsions, Parkinson’s disease and stimulation. Lancet. 2002;360(9342):1302–4.

  21. 21.

    Fontaine D, Mattei V, Borg M, et al. Effect of subthalamic nucleus stimulation on obsessive-compulsive disorder in a patient with Parkinson’s disease. Case report. J Neurosurg. 2004;100(6):1084–6.

  22. 22.

    •• Mallet L, Polosan M, Jaafari N, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 2008;359(20):2121–34. This STN DBS study in 16 patients reported Y-BOCS score reductions of 25% or more in 75% of study participants. However, the authors reported a relatively high number of adverse events.

  23. 23.

    Greenberg BD, Rauch SL, Haber SN. Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology. 2010;35:317–36.

  24. 24.

    • Jimenez-Ponce F, Velasco-Campos F, Castro-Farfan G, et al. Preliminary study in patients with obsessive-compulsive disorder treated with electrical stimulation in the inferior thalamic peduncle. Neurosurgery. 2009;65(6 Suppl):203–9. This open-protocol study is the only clinical investigation of DBS of the ITP. It reported five of five responders.

  25. 25.

    Seijo FJ, Alvarez-Vega MA, Gutierrez JC, et al. Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson’s disease. Review of 272 procedures. Acta Neurochir. 2007;149:867–75.

  26. 26.

    Maldonado IL, Roujeau T, Cif L, et al. Magnetic resonance-based deep brain stimulation technique: a series of 478 consecutive implanted electrodes with no perioperative intracerebral hemorrhage. Neurosurgery. 2009;65(6):196–201.

  27. 27.

    Ben-Haim S, Asaad WF, Gale JT, et al. Risk factors for hemorrhage during micro-electrode deep brain stimulation and the induction of an improved microelectrode design. Neurosurgery. 2009;64(4):754–62.

  28. 28.

    Oh MY, Abosch A, Kim SH, et al. Long-term hardware-related complications of deep brain stimulation. Neurosurgery. 2002;50:1268–74.

  29. 29.

    Okun MS, Man G, Foote KD, et al. Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming. J Neurol Neurosurg Psychiatry. 2007;78(3):310–4.

  30. 30.

    Shapira NA, Okun MS, Wint D, et al. Panic and fear induced by deep brain stimulation. J Neurol Neurosurg Psychiatry. 2006;77:410–2.

  31. 31.

    Haq IU, Foote KD, Goodman WK, et al. A case of mania following deep brain stimulation for obsessive compulsive disorder. Stereotact Funct Neurosurg. 2010;88:322–8.

  32. 32.

    Tsai HC. Hypomania following bilateral ventral capsule stimulation in a patient with refractory obsessive-compulsive disorder. Biol Psychiatry. 2010;68:e7–8.

  33. 33.

    Kuhn J, Lenarz D, Huff W, et al. Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications. J Neurol Neurosurg Psychiatry. 2007;78(10):1152–3.

  34. 34.

    Mantione M, van den Brink W, Denys D, et al. Smoking cessation and weight loss after chronic deep brain stimulation of the nucleus accumbens: therapeutic and research implications: case report. Neurosurgery. 2010;66(1):E218.

  35. 35.

    Kuhn J, Bauer R, Pohl S, et al. Observations on unaided smoking cessation after deep brain stimulation of the nucleus accumbens. Eur Addict Res. 2009;15(4):196–201.

  36. 36.

    Whiteside SP, Prt JD, Abramowitz JS, et al. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res. 2004;132(1):69–79.

  37. 37.

    • McIntyre CC, Hahn PJ. Network perspectives on the mechanisms of deep brain stimulation. Neurobiol Dis. 2010;38(3):329–37. This review covers the network-based theories on the function and pathophysiology of the cortico-basal-ganglia-thalamo-cortical loops commonly targeted by DBS.

  38. 38.

    Meissner W, Leblois A, Hansel D, et al. Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain. 2005;128(10):2372–82.

  39. 39.

    • Le Jeune F, Verin M, N’Diaye K, et al. Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study. Biol Psychiatry. 2010;68:1016–22. This PET study investigated the neural substratum of STN DBS in an on–off phase in 10 patients. The results suggested that the therapeutic effect of STN stimulation is related to a decrease in prefrontal cortex metabolism.

  40. 40.

    Rauch SL, Dougherty DD, Malone D, et al. A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder. J Neurosurg. 2006;104(4):558–65.

  41. 41.

    Okun MS, Bowers D, Springer U, et al. Intra-operative observations of contralateral smiles induced by deep brain stimulation. Neurocase. 2003;10:271–9.

  42. 42.

    Haq IU, Foote KD, Goodman WG, et al. Smile and laughter induction and intraoperative predictors of response to deep brain stimulation of obsessive compulsive disorder. Neuroimage. 2010;54:S246–55.

Download references

Disclosure

Dr. Schuurman has served as a consultant for, received honoraria for service on an expert safety board from, and had travel expenses reimbursed by Medtronic. Drs. De Koning, Figee, van den Munckhof, and Denys reported no potential conflicts of interest relevant to this article.

Author information

Correspondence to Damiaan Denys.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

de Koning, P.P., Figee, M., van den Munckhof, P. et al. Current Status of Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Clinical Review of Different Targets. Curr Psychiatry Rep 13, 274–282 (2011). https://doi.org/10.1007/s11920-011-0200-8

Download citation

Keywords

  • Deep brain stimulation
  • Obsessive-compulsive disorder
  • Neurosurgery
  • Nucleus accumbens
  • Internal capsule
  • Ventral capsule
  • Ventral striatum
  • Subthalamic nucleus
  • Inferior thalamic peduncle
  • Neuroimaging
  • PET
  • MRI
  • SPECT
  • Parkinson
  • Adverse events
  • Cognitive function
  • CTSC
  • Responder
  • Y-BOCS